{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:25:31Z","timestamp":1794457531862,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cancer Policy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jcpo.2025.100675","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:15:26Z","timestamp":1765037726000},"page":"100675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Economic evaluation of the one-dose HPV vaccination program in Nigeria"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7306-1474","authenticated-orcid":false,"given":"Tianjiao","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Farag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohail","family":"Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Mobula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3473-3638","authenticated-orcid":false,"given":"Wu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcpo.2025.100675_bib1","unstructured":"L. Bruni, Albero, G., Serrano, B., Mena, M., Collado, J.J., G\u00f3mez, D., Mu\u00f1oz, J., Bosch, F.X., de Sanjos\u00e9, S., Human Papillomavirus and Related Diseases in Nigeria. Summary Report 10 March 2023., ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre), 2023."},{"key":"10.1016\/j.jcpo.2025.100675_bib2","unstructured":"Johns Hopkins University, One dose at a time: Mobilizing to eliminate cervical cancer in Nigeria, 2024. \u3008https:\/\/publichealth.jhu.edu\/ivac\/2024\/one-dose-at-a-time-mobilizing-to-eliminate-cervical-cancer-in-nigeria\u3009. (Accessed August 22 2025)."},{"key":"10.1016\/j.jcpo.2025.100675_bib3","unstructured":"United Nations Children's Fund, HPV vaccination campaign protects girls in Nigeria, 2024. \u3008https:\/\/www.unicefusa.org\/stories\/hpv-vaccination-campaign-protects-girls-nigeria\u3009. (Accessed August 22 2025)."},{"issue":"32","key":"10.1016\/j.jcpo.2025.100675_bib4","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1016\/j.vaccine.2008.04.053","article-title":"Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries","volume":"26","author":"Goldie","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jcpo.2025.100675_bib5","doi-asserted-by":"crossref","first-page":"F60","DOI":"10.1016\/j.vaccine.2012.07.093","article-title":"Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa","volume":"31","author":"Kim","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jcpo.2025.100675_bib6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1186\/s12913-017-2758-2","article-title":"Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage","volume":"17","author":"Ekwunife","year":"2017","journal-title":"BMC Health Serv. Res"},{"key":"10.1016\/j.jcpo.2025.100675_bib7","series-title":"Cost of introducing human papillomavirus vaccination into Nigeria\u2019s expanded program on immunization: lessons from two Nigerian states","author":"Salihu","year":"2025"},{"key":"10.1016\/j.jcpo.2025.100675_bib8","unstructured":"United Nations Children's Fund Supply Division, Human papillomavirus vaccine: Supply and demand update, 2019. \u3008https:\/\/www.unicef.org\/supply\/media\/22346\/file\/Human-Papillomavirus-Vaccine-Market-Update-December2019.pdf\u3009. (Accessed August 28 2025)."},{"key":"10.1016\/j.jcpo.2025.100675_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.vhri.2015.10.010","article-title":"Cost-utility analysis of human papillomavirus vaccination and cervical screening on cervical cancer patient in Indonesia","volume":"9","author":"Setiawan","year":"2016","journal-title":"Value Health Reg. Issues"},{"issue":"43","key":"10.1016\/j.jcpo.2025.100675_bib10","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1016\/j.vaccine.2009.07.026","article-title":"Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis","volume":"27","author":"Ginsberg","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jcpo.2025.100675_bib11","unstructured":"Institute for Health Metrics and Evaluation, GBD results, 2025. \u3008https:\/\/vizhub.healthdata.org\/gbd-results\/\u3009. (Accessed August 25 2025)."},{"issue":"3","key":"10.1016\/j.jcpo.2025.100675_bib12","article-title":"Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases","volume":"24","author":"Clifford","year":"2006","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.jcpo.2025.100675_bib13","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.vaccine.2022.02.080","article-title":"Cost-effectiveness analysis of quadrivalent and nonavalent human papillomavirus vaccines in Ethiopia","volume":"40","author":"Wondimu","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jcpo.2025.100675_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/jncd.jncd_14_23","article-title":"Cervical cancer care cascade among women living with human immunodeficiency virus in 13 sub-Saharan Africa countries between 2019 and 2021: An ecological analysis of PEPFAR Panorama cervical cancer program data","volume":"8","author":"Ng\u2019ambi","year":"2023","journal-title":"Int. J. Noncommun. Dis."},{"issue":"5","key":"10.1016\/j.jcpo.2025.100675_bib15","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.jcpo.2025.100675_bib16","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1016\/j.vaccine.2023.05.019","article-title":"Impact, cost-effectiveness, and budget implications of HPV vaccination in Kenya: a modelling study","volume":"41","author":"Mwenda","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jcpo.2025.100675_bib17","article-title":"Cervical cancer management in a low resource setting: a 10-year review in a tertiary care hospital in Kenya","volume":"51","author":"Shaffi","year":"2024","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.jcpo.2025.100675_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcpo.2024.100518","article-title":"The out-of-pocket cost of breast cancer care in Nigeria: a prospective analysis","volume":"42","author":"Wuraola","year":"2024","journal-title":"J. Cancer Policy"},{"key":"10.1016\/j.jcpo.2025.100675_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2407-13-69","article-title":"Patient side cost and its predictors for cervical cancer in Ethiopia: a cross sectional hospital based study","volume":"13","author":"Hailu","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jcpo.2025.100675_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vhri.2016.03.002","article-title":"Cost-Effectiveness of Screening and Treatment for Cervical Cancer in Tanzania: implications for other Sub-Saharan African countries","volume":"10","author":"Nelson","year":"2016","journal-title":"Value Health Reg. Issues"},{"issue":"1","key":"10.1016\/j.jcpo.2025.100675_bib21","doi-asserted-by":"crossref","first-page":"A85","DOI":"10.1016\/j.vaccine.2021.07.027","article-title":"The projected cost-effectiveness and budget impact of HPV vaccine introduction in Ghana","volume":"40","author":"Vodicka","year":"2022","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jcpo.2025.100675_bib22","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00005650-199806000-00002","article-title":"Toward consistency in cost-utility analyses: using national measures to create condition-specific values","volume":"36","author":"Gold","year":"1998","journal-title":"Med. Care"},{"issue":"4","key":"10.1016\/j.jcpo.2025.100675_bib23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/0272989X07302128","article-title":"Abnormal outcomes following cervical cancer screening: event duration and health utility loss","volume":"27","author":"Insinga","year":"2007","journal-title":"Med. Decis. Mak."},{"key":"10.1016\/j.jcpo.2025.100675_bib24","unstructured":"World Health Organization, WHO Guide for Standardization of Economic Evaluations of Immunization Programmes, second ed., World Health Organization, 2019. \u3008https:\/\/iris.who.int\/bitstream\/handle\/10665\/329389\/WHO-IVB-19.10-eng.pdf\u3009. (Accessed August 26 2025)."},{"issue":"4","key":"10.1016\/j.jcpo.2025.100675_bib25","doi-asserted-by":"crossref","first-page":"e662","DOI":"10.1016\/S2214-109X(23)00597-1","article-title":"Implementation strategies to build mental health-care capacity in Malawi: a health-economic evaluation","volume":"12","author":"Yanguela","year":"2024","journal-title":"Lancet Glob. Health"},{"issue":"11","key":"10.1016\/j.jcpo.2025.100675_bib26","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2471\/BLT.17.207100","article-title":"Cost-effectiveness of results-based financing, Zambia: a cluster randomized trial","volume":"96","author":"Zeng","year":"2018","journal-title":"Bull. World Health Organ."},{"issue":"1","key":"10.1016\/j.jcpo.2025.100675_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12916-023-02988-3","article-title":"Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis","volume":"21","author":"Prem","year":"2023","journal-title":"BMC Med."},{"issue":"11","key":"10.1016\/j.jcpo.2025.100675_bib28","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S1470-2045(21)00453-8","article-title":"Vaccine efficacy against persistent human papillomavirus (HPV) 16\/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study","volume":"22","author":"Basu","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcpo.2025.100675_bib29","author":"World Health Organization","year":"2022"},{"key":"10.1016\/j.jcpo.2025.100675_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106399","article-title":"HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019","volume":"144","author":"Bruni","year":"2021","journal-title":"Prev. Med"},{"issue":"1","key":"10.1016\/j.jcpo.2025.100675_bib31","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1186\/s12913-023-10283-3","article-title":"Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study","volume":"23","author":"Kiendrebeogo","year":"2023","journal-title":"BMC Health Serv. Res"},{"key":"10.1016\/j.jcpo.2025.100675_bib32","unstructured":"Pan American Health Organization, Revolving Fund Vaccine Prices 2025, 2025.\u3008https:\/\/www.paho.org\/en\/documents\/revolving-fund-vaccine-prices-2025\u3009. (Accessed Oct 15, 2025)."},{"issue":"12","key":"10.1016\/j.jcpo.2025.100675_bib33","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1038\/s41591-023-02600-4","article-title":"Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population","volume":"29","author":"Simms","year":"2023","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/j.jcpo.2025.100675_bib34","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1002\/cncr.34404","article-title":"Improved survival in cervical cancer patients receiving care at national cancer institute-designated cancer centers","volume":"128","author":"McDaniels-Davidson","year":"2022","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jcpo.2025.100675_bib35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12885-021-07847-z","article-title":"Knowledge, attitudes, and practice of cervical cancer prevention among health workers in rural health centres of Northern Uganda","volume":"21","author":"Obol","year":"2021","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.jcpo.2025.100675_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/inthealth\/ihaa062","article-title":"A comparative analysis of cervical cancer prevention between Nigeria and Nordic countries that have experienced a decline in cervical cancer incidence","volume":"13","author":"Anyasi","year":"2021","journal-title":"Int Health"},{"issue":"2","key":"10.1016\/j.jcpo.2025.100675_bib37","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1093\/infdis\/jiaf121","article-title":"Strong herd effects of human papillomavirus vaccination","volume":"232","author":"Chesson","year":"2025","journal-title":"J. Infect. Dis."}],"container-title":["Journal of Cancer Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538325001195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538325001195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T22:50:30Z","timestamp":1772923830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213538325001195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":37,"alternative-id":["S2213538325001195"],"URL":"https:\/\/doi.org\/10.1016\/j.jcpo.2025.100675","relation":{},"ISSN":["2213-5383"],"issn-type":[{"value":"2213-5383","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic evaluation of the one-dose HPV vaccination program in Nigeria","name":"articletitle","label":"Article Title"},{"value":"Journal of Cancer Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcpo.2025.100675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100675"}}